Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness
- 1 July 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354 (9174) , 210-215
- https://doi.org/10.1016/s0140-6736(99)90001-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up Commentary: Progress on nicotine replacement therapy for smokersBMJ, 1999
- How much does relapse after one year erode effectiveness of smoking cessation treatments? Long term follow up of randomised trial of nicotine nasal sprayBMJ, 1998
- The Cost-Effectiveness of the Nicotine Transdermal Patch for Smoking CessationPreventive Medicine, 1997
- Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practiceAddiction, 1995
- Smoking and death: the past 40 years and the next 40BMJ, 1994
- Mortality in relation to smoking: 40 years' observations on male British doctorsBMJ, 1994
- Randomised trial of nicotine patches in general practice: results at one yearBMJ, 1994
- Predicting Smoking CessationJAMA, 1994
- Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.BMJ, 1993
- Cost-effectiveness of Nicotine Gum as an Adjunct to Physician's Advice Against Cigarette SmokingJAMA, 1986